BICO Group AB
STO:BICO

Watchlist Manager
BICO Group AB Logo
BICO Group AB
STO:BICO
Watchlist
Price: 36.4 SEK 5.14% Market Closed
Market Cap: 2.5B SEK
Have any thoughts about
BICO Group AB?
Write Note

BICO Group AB
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BICO Group AB
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
BICO Group AB
STO:BICO
Current Portion of Long-Term Debt
kr102.1m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Current Portion of Long-Term Debt
kr1.4B
CAGR 3-Years
34%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Current Portion of Long-Term Debt
kr33m
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
52%
G
Genovis AB
STO:GENO
Current Portion of Long-Term Debt
kr2.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Current Portion of Long-Term Debt
kr51.4m
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-8%
M
Magle Chemoswed Holding AB
STO:MAGLE
Current Portion of Long-Term Debt
kr4.3m
CAGR 3-Years
-30%
CAGR 5-Years
20%
CAGR 10-Years
N/A
No Stocks Found

BICO Group AB
Glance View

Market Cap
2.6B SEK
Industry
Life Sciences Tools & Services

BICO Group AB is a bioconvergence company, which engages in the provision of technologies, products, and services to create, understand and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 890 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

BICO Intrinsic Value
61.41 SEK
Undervaluation 41%
Intrinsic Value
Price

See Also

What is BICO Group AB's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
102.1m SEK

Based on the financial report for Dec 31, 2023, BICO Group AB's Current Portion of Long-Term Debt amounts to 102.1m SEK.

What is BICO Group AB's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
67%

Over the last year, the Current Portion of Long-Term Debt growth was 5%. The average annual Current Portion of Long-Term Debt growth rates for BICO Group AB have been 67% over the past three years .

Back to Top